Clonal competition and disrupted molecular processes in chronic lymphocytic leukemia.

Investor logo

Warning

This publication doesn't include Faculty of Education. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Authors

ZÁVACKÁ Kristýna TAUŠ Petr PÁL Karol PORC Jakub Paweł PAVLOVÁ Šárka MALČÍKOVÁ Jitka STRÁNSKÁ Kamila ŽENATOVÁ Marcela TICHÝ Boris BLAVET Nicolas PANOVSKÁ Anna DOUBEK Michael POSPÍŠILOVÁ Šárka PLEVOVÁ Karla

Year of publication 2023
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology

Citation
Attached files
Description Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in Western countries. Due to dynamic clonal changes in a leukemic cell population over time, CLL is characterized by a highly variable clinical course. The expansion of subclones with different gene mutations, many of which are non-recurrent, makes CLL challenging to treat. We aimed to describe the clonal evolution in CLL, focusing on specific treatments and different stages of the disease. As defects in the TP53 gene are strong predictive and prognostic markers in CLL and drive chemoimmunotherapy resistance, we particularly studied factors influencing the clonal development of TP53-mutated subclones.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.